Cocrystal Pharma, Inc. (COCP) vs Vyome Holdings, Inc. (HIND)
A side-by-side comparison of Cocrystal Pharma, Inc. and Vyome Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COCP
Cocrystal Pharma, Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
HIND
Vyome Holdings, Inc.
$2.01HealthcareDelayed quote: Oct 6, 2026, 3:28 PM EDT
Total return — COCP vs HIND
growth of $100 · dividends reinvested · last 10yCOCP -99.4% (-39.6%/yr)HIND -100.0% (-84.2%/yr)COCP compounded faster over this window
Log scale — wide-divergence pair
COCP HIND
COCP vs HIND: by the numbers
- •COCP is the larger company ($15M vs $14M market cap).
- •Both run net losses; COCP's is the smaller (-3011.52% vs -8716.77% net margin).
- •COCP grew revenue faster over the past five years (91.55% vs -60.54% CAGR).
Metrics side by side
Valuation
| Metric | COCP | HIND |
|---|---|---|
| P/S ratio | 46.17 | 108.80 |
| P/B ratio | 14.59 | 2.33 |
| FCF yield | N/A | 3.72% |
Profitability
| Metric | COCP | HIND |
|---|---|---|
| Gross margin | 0.00% | 64.68% |
| Operating margin | 0.00% | -859.22% |
| Net margin | -3011.52% | -8716.77% |
| ROE | -951.92% | -186.95% |
| ROIC | -497.29% | -57.53% |
Growth (annualized)
| Metric | COCP | HIND |
|---|---|---|
| Revenue CAGR (5Y) | 91.55% | -60.54% |
| Total return CAGR (5Y) | -37.50% | -92.93% |
Frequently asked
- Which has grown faster, COCP or HIND?
- Over the past five years, COCP grew revenue faster — COCP at a 91.55% CAGR versus HIND at -60.54%.
- How have COCP and HIND total returns compared?
- Over the past 5 years, COCP delivered -37.50% and HIND delivered -92.93% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cocrystal Pharma ROEVyome ROECocrystal Pharma operating marginVyome operating marginCocrystal Pharma revenue growthVyome revenue growthCocrystal Pharma free cash flowVyome free cash flow
Cocrystal Pharma & Vyome appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.